您当前的位置:WAY 316606

WAY 316606

时间:2023-07-15  来源:化工号   作者:C18H19F3N2O4S2
  • 方式 316606
  • 化合物WAY 316606
  • SFRP-1抑制剂(WAY 316606)
  • 5-(苯磺酰基)-N-(哌啶-4-基)-2-(三氟甲基)苯磺酰胺
  • 中文名 WAY 316606
    英文名 WAY 316606
    别名 方式 316606
    化合物WAY 316606
    SFRP-1抑制剂(WAY 316606)
    5-(苯磺酰基)-N-(哌啶-4-基)-2-(三氟甲基)苯磺酰胺
    英文别名 CS-2786
    WAY316606
    WAY-316606
    WAY 316606
    5-(benzenesulfonyl)-N-piperidin-4-yl-2-(trifluoromethyl)benzenesulfonamide
    BenzenesulfonaMide, 5-(phenylsulfonyl)-N-4-piperidinyl-2-(trifluoroMethyl)-
    5-(Phenylsulfonyl)-N-(piperidin-4-yl)-2-(trifluoromethyl)benzenesulfonamide
    CAS 915759-45-4
    EINECS 1592732-453-0
    化学式 C18H19F3N2O4S2
    分子量 448.4796696
    密度 1.50±0.1 g/cm3(Predicted)
    沸点 601.1±65.0 °C(Predicted)
    酸度系数 8.76±0.20(Predicted)
    存储条件 2-8℃
    体外研究 The EC 50 of WAY-316606 for Wnt-Luciferase Activity from U2-OS Cells is 0.65 μM. WAY-316606 binds to secreted frizzled-related protein (sFRP)-1 inhibitor with a K D of 0.08 μM and inhibits sFRP-1 with an EC 50 of 0.65 μM. WAY-316606 also binds to sFRP-2, albeit over 10 times weaker with a K D of 1 μM. Using a fluorescence polarization binding assay that employs a fluorescent probe compound and purified human sFRP-1 protein in a competitive-binding format, the IC 50 for WAY-316606 is 0.5 μM.
    体内研究 WAY-316606 increases bone formation when tested in a neonatal murine calvarial assay. WAY-316606 increases total bone area up to 60% in a dose-dependent manner with an EC 50 of about 1 nM. WAY-316606 has good aqueous solubility, moderate to low inhibition of cytochrome p450 isozymes (3A4, 2D6, 2C9) and good stability in rat and human liver microsomes (t 1/2 >60 min in each species). In female Sprague-Dawley rats, WAY-316606 exhibits high plasma clearance (77 mL/min/kg, greater than hepatic blood flow) following a single intravenous bolus dose (2 mg/kg), which results in a rapid decline of drug exposure in the plasma despite the route of administration.
    来顶一下
    返回首页
    返回首页
    推荐资讯
    热门点击